Sook-Kwan Leang

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017

Angie Lackenby, Terry G. Besselaar, Rod S. Daniels et al. · Antiviral Research · 2018 · 136 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses

Jeff Butler, Kathryn A. Hooper, Stephen Petrie et al. · PLoS Pathogens · 2014 · 125 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility

Rubaiyea Farrukee, Sook-Kwan Leang, Jeff Butler et al. · Journal of Antimicrobial Chemotherapy · 2015 · 35 citations

Life Sciences, Infectious Diseases, Pharmacology +17

Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring

Karen Little, Sook-Kwan Leang, Jeff Butler et al. · Eurosurveillance · 2015 · 31 citations · Full text

Life Sciences, Infectious Diseases, Molecular Virology +16